UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mitochondrial Fission Mediates Endothelial Inflammation

Hypertension (Dallas, Tex. 1979), 2020-07, Vol.76 (1), p.267-276

2020

Volltextzugriff (PDF)

High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy

Clinical cancer research, 2010-12, Vol.16 (23), p.5805-5813

2010

Volltextzugriff (PDF)

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Journal of thoracic oncology, 2017-09, Vol.12 (9), p.1421-1433

2017

Volltextzugriff (PDF)

Duration of Chemotherapy for Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials

Journal of clinical oncology, 2009-07, Vol.27 (20), p.3277-3283

2009

Volltextzugriff (PDF)

Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II

Hypertension (Dallas, Tex. 1979), 2017-01, Vol.69 (1), p.79-86

2017

Volltextzugriff (PDF)

Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-10, Vol.27 (30), p.5080-5087

2009

Volltextzugriff (PDF)

Involvement of Senescence and Mitochondrial Fission in Endothelial Cell Pro-Inflammatory Phenotype Induced by Angiotensin II

International journal of molecular sciences, 2020-04, Vol.21 (9), p.3112

2020

Volltextzugriff (PDF)

Endothelial cell-derived extracellular vesicles alter vascular smooth muscle cell phenotype through high-mobility group box proteins

Journal of extracellular vesicles, 2020-01, Vol.9 (1), p.1781427-n/a

2020

Volltextzugriff (PDF)

Quality of Life and Survival in the 2 Years After Surgery for Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2008-01, Vol.26 (2), p.233-241

2008

Volltextzugriff (PDF)

Transduction Efficiency of Adenovirus Vectors in Endothelial Cells and Vascular Smooth Muscle Cells

Journal of cardiovascular pharmacology, 2020-06, Vol.75 (6), p.603-607

2020

Volltextzugriff (PDF)

Somatic mutations in salivary duct carcinoma and potential therapeutic targets

Oncotarget, 2017-09, Vol.8 (44), p.75893-75903

2017

Volltextzugriff (PDF)

Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling

Cancer research (Chicago, Ill.), 2009-10, Vol.69 (19), p.7696-7703

2009

Volltextzugriff (PDF)

Randomized Controlled Trial of the Role of Positron Emission Tomography in the Management of Stage I and II Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2004-06, Vol.22 (12), p.2357-2362

2004

Volltextzugriff (PDF)

Patterns of DNA Mutations and ALK Rearrangement in Resected Node Negative Lung Adenocarcinoma

Journal of thoracic oncology, 2013-04, Vol.8 (4), p.408-414

2013

Volltextzugriff (PDF)

Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial

JNCI : Journal of the National Cancer Institute, 2010-08, Vol.102 (16), p.1253-1262

2010

Volltextzugriff (PDF)

Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial

JTO clinical and research reports, 2024-07, Vol.5 (7), p.100685, Article 100685

2024

Volltextzugriff (PDF)

Postprogression Outcomes for Osimertinib versus Standard-of-Care EGFR-TKI in Patients with Previously Untreated EGFR-mutated Advanced Non-Small Cell Lung Cancer

Clinical cancer research, 2019-04, Vol.25 (7), p.2058-2063

2019

Volltextzugriff (PDF)

Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II/β-Aminopropionitrile–Induced Abdominal Aortic Aneurysm

Hypertension (Dallas, Tex. 1979), 2017-11, Vol.70 (5), p.959-963

2017

Volltextzugriff (PDF)

ALK‐Rearranged Non‐Small Cell Lung Cancer in 2020: Real‐World Triumphs in an Era of Multigeneration ALK‐Inhibitor Sequencing Informed by Drug Resistance Profiling

The oncologist (Dayton, Ohio), 2020-08, Vol.25 (8), p.641-649

2020

Volltextzugriff (PDF)

Evolving Landscape of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Journal of clinical oncology, 2016-09, Vol.34 (27), p.3233-3234

2016

Volltextzugriff (PDF)

Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms

Journal of clinical medicine, 2018-06, Vol.7 (6), p.151

2018

Volltextzugriff (PDF)

Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men

Arteriosclerosis, thrombosis, and vascular biology, 1997-10, Vol.17 (10), p.2004-2009

1997

Volltextzugriff (PDF)

Multi-center phase 1 safety and efficacy study of nivolumab in renal transplant patients with metastatic malignancy

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2567-2567

2021

Volltextzugriff (PDF)

A retrospective cohort analysis of return-to-work outcomes for cancer survivors using a digital coaching intervention

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1566-1566

2022

Volltextzugriff (PDF)

IMPRINTER: An open label, multicenter, dose escalation/expansion, phase 1 study of imu-201 (PD1-Vaxx), a B-cell immunotherapy as monotherapy or in combination with atezolizumab, in adults with non-small cell lung cancer (IMU.201.101)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e21134-e21134

2022

Volltextzugriff (PDF)

1 – 25 von 478

Suche als RSS-Feed

Aktive Filter

KollektionEZB Free E-Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(457)
Mit Volltextzugriff
(457)

Publikationsform

Artikel
(478)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(316)
Life Sciences & Biomedicine
(263)
Humans
(177)
Male
(105)
Female
(99)
Biological And Medical Sciences
(80)
Animals
(79)
Middle Aged
(66)
Oncology
(66)
Adult
(60)
Medical Sciences
(60)
Aged
(51)
Mice
(41)
General & Internal Medicine
(34)
Physical Sciences
(33)
Immunology
(31)
Medicine, General & Internal
(30)
Multidisciplinary Sciences
(27)
Science & Technology - Other Topics
(27)
Aged, 80 And Over
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Mitochondrial Fission Mediates Endothelial Inflammation

High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic Therapy

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma

Duration of Chemotherapy for Advanced Non–Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials

Caveolin-1 Deletion Prevents Hypertensive Vascular Remodeling Induced by Angiotensin II

Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Involvement of Senescence and Mitochondrial Fission in Endothelial Cell Pro-Inflammatory Phenotype Induced by Angiotensin II

Endothelial cell-derived extracellular vesicles alter vascular smooth muscle cell phenotype through high-mobility group box proteins

Quality of Life and Survival in the 2 Years After Surgery for Non–Small-Cell Lung Cancer

Transduction Efficiency of Adenovirus Vectors in Endothelial Cells and Vascular Smooth Muscle Cells

Somatic mutations in salivary duct carcinoma and potential therapeutic targets

Identification of Candidate Biomarkers of Therapeutic Response to Docetaxel by Proteomic Profiling

Randomized Controlled Trial of the Role of Positron Emission Tomography in the Management of Stage I and II Non-Small-Cell Lung Cancer

Patterns of DNA Mutations and ALK Rearrangement in Resected Node Negative Lung Adenocarcinoma

Comparison of Two Standard Chemotherapy Regimens for Good-Prognosis Germ Cell Tumors: Updated Analysis of a Randomized Trial

Avelumab in Combination With Lorlatinib or Crizotinib in Patients With Previously Treated Advanced NSCLC: Phase 1b/2 Results From the JAVELIN Lung 101 Trial

Postprogression Outcomes for Osimertinib versus Standard-of-Care EGFR-TKI in Patients with Previously Untreated EGFR-mutated Advanced Non-Small Cell Lung Cancer

Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II/β-Aminopropionitrile–Induced Abdominal Aortic Aneurysm

ALK‐Rearranged Non‐Small Cell Lung Cancer in 2020: Real‐World Triumphs in an Era of Multigeneration ALK‐Inhibitor Sequencing Informed by Drug Resistance Profiling

Evolving Landscape of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors

Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms

Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men

Multi-center phase 1 safety and efficacy study of nivolumab in renal transplant patients with metastatic malignancy

A retrospective cohort analysis of return-to-work outcomes for cancer survivors using a digital coaching intervention

IMPRINTER: An open label, multicenter, dose escalation/expansion, phase 1 study of imu-201 (PD1-Vaxx), a B-cell immunotherapy as monotherapy or in combination with atezolizumab, in adults with non-small cell lung cancer (IMU.201.101)

Aktive Filter

Suchergebnisse filtern